Lactobacillus plantarum bacteria strain having wide range of antagonistic activity with respect to pathogens and opportunistic pathogens

FIELD: chemistry.

SUBSTANCE: invention relates to biochemistry and biotechnology and can be used in production of probiotic bacterial preparations, biologically active food additives, fermented milk and non-fermented food products. The Lactobacillus plantarum VKPM V-11154 strain has high antagonistic activity with respect to pathogens and opportunistic pathogens, including Candida yeast fungi. The strain is phenotypically apathogenic, has average adhesion and self-aggregation properties, high surface hydrophobicity, average coaggregation; hydrochloric acid has minimum inhibiting concentration of 1.25%; the bile stimulates propagation and growth of the culture.

EFFECT: invention enables faster accumulation of biomass with high concentration of lactic bacteria on artificial nutrient media.

2 dwg, 5 tbl

 

The invention relates to biotechnology, food processing and medical industry and can be used in the production of preparations containing live bacteria, biologically active additives to food, fermented milk fermented and non-fermented foods.

At present, the urgent and important task is the development of new antimicrobial drugs probiotics containing new, non-toxic, bioavailable strains of microorganisms which can be in the form of mono - and mixed cultures to use in the composition of probiotic preparations and food products. Probiotic cultures differ in range and potency, adhesion, sensitivity to antimicrobial agents, resistance to the action of bile, digestive enzymes, growth on nutrient media, the ability to skachivat milk etc.

When different aftercare of acute intestinal infections and with the dysbacteriosis of various etiologies widely used probiotic preparation Lactobacterin, based on the strain Lactobacillus plantarum 8A-P3 [Ukr. microbiol. 2004. No. 1. P.84-92.] However, in the treatment of acute intestinal diseases, this drug is not effective enough.

Known for a number of probiotic strains Lactobacillus salivarius (EN 2302458) these strains isolated from resected and washed human Ictservice and are antagonistic towards L.innocua, L.fermentum KLD, P.fluorescens, E.coli V 157. Strains are characterized by their sensitivity to a number of antimicrobial agents (ampicillin, amoxicillin, cefixim, Ceftriaxone, ciprofloxacin, cefradine, rifampicin, chloramphenicol), resistant to physiological concentrations of hydrochloric acid and bile, have the ability to adhesives to the epithelial cells of the gastrointestinal tract. However, the range of their antagonistic activity does not include yeast-like fungi of the genus Candida, which is relevant for today.

Object of the invention is to widen the range of strains with antagonistic activity.

The problem is solved by the fact that the resulting strain Lactobacillus plantarum C with high antagonistic activity against pathogenic and conditionally pathogenic microorganisms, including in relation to yeast Candida.

Lactobacillus plantarum C isolated from faeces of healthy girls at the age of 20 years, which at the time of examination was clinically healthy, had no history of infectious and somatic diseases of the gastrointestinal tract and other organ systems, by separating the pure culture by rascaroli investigated material and sowing at the optimum nutrient medium (MRS agar, lacto-agar MRS broth). The cultivation was carried out without the use of genetic methods m the modification is at a temperature of 37°C for 24 hours in a desiccator with a candle with a higher content of CO 2on the basis of the bacteriological laboratory of the Department of Microbiology, Virology and immunology GBOU VPO Tver state medical Academy of the Ministry of health and social development of Russia.

The resulting strain deposited in Russian national collection of industrial microorganisms FSUE gosniigenetika, Moscow (1st Road Ave, 1) and has the registration number VKPM B-11154.

The resulting strain is characterized by the following features:

Cultural morphological traits

When using the microscope, the cells are fixed, short and long large sticks of the correct form with rounded ends, single, surrounded by a capsule. In young culture there are cells in pairs, some are in the chain.

The size of the cells varies during growth on different nutrient media in the range of 0.5 to 1.2×1.0 to 10 μm. Gram-positive.

When grown on MRS agar (Difco™ Lactobacilli MRS Agar) and lacto-agar (fsri State research center for applied Microbiology and biotechnology goblins) at 37±1°C under anaerobic conditions using microbiostatic and GasPak system+in a desiccator with a candle with a higher content of CO2and aerobic mode within 24-48 hours of the colony S-shape of 1-2 mm, convex, smooth, gray-yellow or white with smooth edges.

When grown in MRS broth (Difco™ Lactobacilli MRS Broth) when temperature is re 37±1°C for 24-48 hours in aerobic conditions, growth as the turbidity of the broth and the loss of white-gray sediment at the bottom.

On protein environments (MPA, MPB, milk) no growth (sometimes there is very little development). Starch is not hydrolyses. The gelatin liquefies.

Physiological and biochemical characteristics

The species is mesophilous, growth is possible in the range of 20-40°C, the optimal growth temperature of 37±1°C.

Optional gone anaerobic. In submerged fermentation liquid nutrient medium optimum aeration-mixing 1 volume of air/volume 1 nutrient medium, which corresponds to sulfite number 1.

For optimal growth pH of 6.5±0,2.

The sources of carbohydrates

Grows well in: D-melibiose, D-ribose, D-galactose, D-glucose, D-fructose, D-mannose, D-saccharose, D-maltose, D-lactose, D-cellobiose, N-acetylglucosamine, methyl - D-mannopyranoside, citrate esculin iron, salicia, arbutin, amygdalin, D-trehalose, D-melezitose, gentiobiose, D-raffinose.

Not growing on: methyl - D-glucopyranoside, L-rhamnose, D - and L-xylose, D-arabinose, L-arabinose, methyl-D-xylopyranoside, L-sorbose, inulin, amidone, D-lyxose, D - and L-fucose, D-turanose, D - and L-arabitol, D-tagatose.

From alcohols learns: glycerin, D-mannitol, lactate.

Of the alcohols is not absorbed: D-sorbitol, aritra, D-adonitol, dulcitol, Inositol, xylitol.

Splits: K-gluconate.

Not splits: 2-ketogluconic, 5-ketogluconic is, glycogen.

Not absorbed citrate, cellulose, ethanol, butanol.

Curtailing milk milk 12-14 hours.

The investigated strain phenotypic pathogeny, i.e. does not have hemolytic, proteolytic, medicinskoi, hyaluronidases, the antilysocyme, DNA-Noah and RNA-tion activity.

Antagonistic activity

Study the antagonistic activity was performed by the method described in (Blinkova L.P. Getting tomized new bacterial preparation and study of its biological activity. Abstract. dis. Dr. Biol. Sciences. M, - 1986. - S) on the test strains Staphylococcus aureus was ATSS 25923, Candida albicans was ATSS 885-653, Pseudomonas aeruginosa was ATSS 27853, Shigella sonnei phase I 941, Bacillus subtillis 534, Escherichia coli 25922. Klebsiella pneumoniae K15054. Analysis was performed 24-48 hours incubation at 37°C in thermostat largest zone of no growth of the test cultures. The degree of antagonism was determined by the following criteria: 10 mm or less is low, 10-20 mm - 21 mm - high.

It is shown that the investigated strain inhibits the growth of pathogenic and conditionally pathogenic microorganisms: S.aureus, B.subtilis, E.coli, Sh.sonnei phase I, P.aeruginosa, Klebsiella pneumoniae and yeast-like fungi C.albicans (table 1).

Relation to antibacterial drugs

The ratio of the strain Lactobacillus plantarum C to antimicrobial agents (kachestvennno) was performed in accordance with methods recommended by the Scientific and the nama Mala research center pharmacotherapy (NICF) www.nicf.spb.ru.

Studies have shown that the claimed strain has sensitivity to ampicillin, gentamicin, streptomycin, tetracycline, rifampin, Meropenem, linezolid, as well as intermediate sensitivity to eritromicina, doxycycline, furadonin (table 2).

Lactobacillus plantarum C permanently stored in cryovials at trypticase-soy broth (TSB) (TSB: Difco Laboratories, Detroit, Mich.) with 15% glycerol in a freezer at a temperature of -80°C to 5 years or -20°C up to 3-6 months, and in dried form for more than 10 years.

The claimed solution is illustrated by the following figures:

Figure 1 the sensitivity of the strain Lactobacillus plantarum K for the hydrochloric acid.

Figure 2 sensitivity of the strain Lactobacillus plantarum C to bile.

The invention is illustrated by the following examples:

Example 1. Cultivation of Lactobacillus plantarum C in laboratory conditions

Lactobacillus plantarum C grown in flasks in liquid nutrient medium MRS broth (Difco™ Lactobacilli MRS Broth) at a temperature of 36±1°C for 24-48 hours under aerobic conditions. The volume of nutrient medium 500 ml Inoculation loop of single isolated colony. After 24 and 48 hours of growth in the form of turbidity of the broth and the loss of white-gray sediment at the bottom. To determine the number of viable lactobacilli are restframe grown bacteria on istoricheskom solution of sodium chloride with W the d 10 and successive planting of different dilutions of 0.3 ml in a dense medium MRS or lactogen. After 24 hours of cultivation at 36±1°C in aerobic conditions shall count colonies and calculate the number of viable microorganisms - colony-forming units (CFU) in 1 ml of liquid nutrient medium (MRS broth). By understanding it is established that after 24 hours of cultivation, the number of grown lactobacilli was 2.7·108-5·108CFU/ml After 48 cultivation - 5·108of 1.3·109CFU/ml

Example 2. The study of the properties of Lactobacillus plantarum C

Acid-forming capability.

The activity of acid generating define out by a titrimetric method (Lanna A.M., Goncharova GI, Vysotsky CENTURIES Morphology of bifidobacteria in optical and electron microscopic level and their biological properties // Microbiology. - 1979. No. 6. - P.54-58.). The measurements were carried out within 72 hours, using a nutrient medium without glucose and with the addition of glucose and taking samples of the culture fluid every 24 hours. The results are expressed in degrees Turner (T°) is a value expressing the amount of 0.1 N. alkali, followed by titration of 100 ml of sample).

The results obtained (table 3) show that during the first day was the acidification of the environment of cultivation without glucose (pH 32°T). In the subsequent gradual increase in acidity, which amounted to 2 succa is 36°T and 3 days at 38°T. After adding on Wednesday glucose as a nutrient substrate following data were obtained: by the end of the first day was observed acidification of the environment (pH - 32°T), to the second day acidity increased to 34°T, to the third day - up to 40°T.

The ability to adhesion

The degree of adhesion of microorganisms determined using an average adhesion (SPA) according to the method of Briles VI (Briles VI, Brylane T.A., Lenzner HP and other techniques for studying adhesion process // lab. case. - 1986. No. 4. - S-212) on human erythrocytes On (I) the group is Rh+.

Studies show that the degree of adhesion of strain L.plantarum K is 2.3±1.2, is the average of.

The ability to autoaggregate

The self-aggregation of lactobacilli determined by the method of A. Andreu et al. (Andreu, A., Stapleton, A., Fennell, C., Hillier, S., and Stamm, E. Hemagglutination, adherence and surface properties of vaginal Lactobacillus species. J. Infect. Dis. - 1995 - 171:1237-1243). The self-aggregation is assessed as the ability to form clusters (aggregates) for 2 minutes. Studies show that the strain L.plantarum C has an average autoaggregate.

The ability to surface hydrophobicity

Surface hydrophobicity of lactobacilli study test salt aggregation (TCA) (Andreu, A., Stapleton, A., Fennell, C., Hillier, S. and Stamm, E. Hemagglutination, adherence and surface properties of vaginal Lactobacillus species. J. Infect. Dis. - 1995 - 171:1237-1243). Studies show that the strain L.plantarum C Bladet high surface hydrophobicity (TCA 0.8 mol/l).

The ability to coaggregation

The ability of lactobacilli to coaggregation determined by the method of G. Reid et al. (Reid G., Mac Groarty, J., Chow, A., Bruce, A., Eisen, A. and Costerton, W. Coaggregation of urogenital bacteria in vitro and in vivo. Curr. Environ. 1990, 20: 47-52). As test crops for this method use the following pathogenic and conditionally-pathogenic strains of Staphylococcus aureus 209, Candida albicans 531, Pseudomonas aeruginosa ATCC 9027, Escherichia coli ATCC 25922; Salmonella typhimurium 11, Shigella flexneri 26, Bacillus subtilis 534. Test coaggregation is considered positive if the studied culture forms aggregates with other species of microorganisms. Studies show that the strain L. plantarum C corregiruet with Staphylococcus aureus, Escherichia coli, Candida albicans, Bacillus subtilis.

Sensitivity to hydrochloric acid and bile

The strain sensitivity for the hydrochloric acid and bile, which largely determines its ability to persistently in the digestive tract, determined by the change in optical density (OD) daily broth culture, depending on the concentration of hydrochloric acid or bile (Casey PG, Casey GD, Gardiner GE et al. (2004) Isolation and characterization of anti-Salmonella lactic acid bacteria from the porcine gastrointestinal tract. Lett Appl Environ 39: 431-438). The measurements were carried out on a spectrophotometer KLF-3 at a wavelength of 590 μm or 600 μm, respectively. As control was used daily net broth culture.

The results show that the minimum inhibitory concentration (MIC) of hydrochloric acid with the hat of 1.25% (table 4 and figure 1), and bile in different concentrations (table 5, figure 2) stimulates proliferation and growth in broth culture of the strain L. plantarum C.

Thus, the claimed strain L.plantarum C VKPM B-11154 high antagonistic activity against pathogenic and conditionally pathogenic microorganisms: S.aureus was ATSS 25923, B.subtilis 534, E.coli was ATSS 25922, Sh.sonnei phase I 941, P.aeruginosa ADS 27853, Klebsiella pneumoniae K15054, and yeast-like fungi C.albicans ADS 885-653. Kislotoproduccia, expressed in degrees Turner, ranges from 32 to 38°T in medium without glucose and from 32 to 40°T adding glucose to the culture medium. L.plantarum C has sensitivity to ampicillin, gentamicin, streptomycin, tetracycline, rifampin, Meropenem, linezolid, as well as intermediate sensitivity to eritromicina, doxycycline, furadonin. The investigated strain phenotypic pathogeny, i.e. does not have hemolytic, proteolytic, medicinskoi, hyaluronidases, the antilysocyme, DNA-Noah and RNA-tion activity. L. plantarum C has an average adhesion (2,3±1,2) and autoaggregation, high surface hydrophobicity (0.8 mol/l) and coaggregation (coaggregation with Staphylococcus aureus, Escherichia coli, Candida albicans, Bacillus subtilis). Minimum inhibitory concentration of hydrochloric acid for L.plantarum C is 1.25%. Bile in various concentrations stimulates reproduction and the OST broth culture of strain L.plantarum C.

The strain of high-tech artificial nutrient media quickly accumulates biomass with a high concentration of lactobacilli.

All this allows us to offer strain L.plantarum C VKPM B-11154 for use in the production of probiotic bacterial preparations, biologically active additives to food, fermented milk fermented and non-fermented food starters, providing probiotic effect and normalization of microbiocenosis of the human body, including the gastrointestinal and urogenital tracts, skin and mucous coats.

Table 1
Spectrum of antagonistic activity of Lactobacillus plantarum C
Zone of inhibition of growth of test cultures in mm
S.aureus was ATSS 25923.subtili s534E.coli was ATSS 25922Sh.sonnei phase I 941P.aeruginosa ATCC 27853Klebsiella pneumoniae K15054C.albicans ATCC 885-653
3024 3827402225
Table 2
The sensitivity of the strain Lactobacillus plantarum C to antibiotics.
№ p/pName antibioticThe degree of sensitivity
1.Penicillin
2.AmpicillinH
3.Vancomycin
4.GentamicinH
5.StreptomycinH
6.ErythromycinP
7. TetracyclineH
8.DoxycyclineP
9.Ciprofloxacin
10.Levofloxacin
11.RifampicinH
12.Chloramphenicol
13.FuradoninP
14.MeropenemH
15.LinezolidH
* note: H - sensitive, N - intermediate, resistant
Table 3
Acid is producing ability of the strain Lactobacillus plantarum C
Strain1 day T°2 day T°3 day T°
L.plantarum Cwithout adding glucose
323638
with the addition of glucose
323440

Table 4
The sensitivity of the strain Lactobacillus plantarum K for the hydrochloric acid
The concentration of HCl, %ControlMICK
52,51,25of 0.6250,31250,15625
OP0,011 0,0090,0140,0380,0310,1to 0.1271,25

Table 5
The sensitivity of the strain Lactobacillus plantarum C to bile
The concentration of bile, %Control
201052,57,25of 0.625
OP0,2530,6050,506value (0.475)0,1030,0920,087

The bacterial strain Lactobacillus plantarum VKPM B-11154 with a broad spectrum of antagonistic activity against pathogenic and conditionally pathogenic microorganisms.



 

Same patents:

FIELD: chemistry.

SUBSTANCE: invention relates to biotechnology. Obtained is a Lactobacillus rhamnosus 38k bacteria strain, having antagonistic activity with respect to pathogens and opportunistic pathogens, including Candida yeast fungi, average adhesion and self-aggregation properties, high surface hydrophobicity, average coaggregation, is deposited in the Russian National Collection of Industrial Microorganisms (VKPM) under registration number VKPM V11155.

EFFECT: strain can be used in production of probiotic bacterial preparations, biologically active food additives, fermented milk and non-fermented food products.

5 tbl

FIELD: chemistry.

SUBSTANCE: method of producing microorganism growth stimulators involves growing Fusarium sambucinum MKF-2001-3 or Fusarium sambucinum BKM F-3051D yeast strains on a medium which contains a source of carbon 3-4%, nitrogen 0.2-0.3%, phosphorus - 0.2-0.3% and trace elements - 0.07-0.08% in sterile conditions at temperature of 26-30°C with stirring and aeration for 40-48 hours. The obtained yeast suspension or culture fluid is titrated with hydrochloric acid to pH=4.0-4.5, heated for 1.0-1.5 hours to 115°C, held for 2 hours, cooled for 1.0-1.5 hours to room temperature.

EFFECT: method provides intense growth of microorganisms by stimulating biological activity of their growth factors which results in more complete recycling of the substrate and increases output of the end product.

10 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to biotechnology, veterinary science and plant protection. The bacterial strain Bacillus subtilis IC-1435-1-1 is deposited in the Russian National Collection of Industrial Microorganisms, registration number B-10641. The bacterial strain Bacillus amyloliquefaciens IC-1436-1-23 is deposited in the Russian National Collection of Industrial Microorganisms, registration number B-10642. The bacterial strain Bacillus amyloliquefaciens IC-1437-1-23 is deposited in the Russian National Collection of Industrial Microorganisms, registration number B-10643. The strains are produced by selection and promote the recovery of microbiocenoses in the soil and animals gastrointestinal tract, possess bactericidal, fungicidal and virucidal activity. A preparation on the basis of the strains contains an excipient or water with a bacterial biomass in the spore form Bacillus subtilis, the Russian National Collection of Industrial Microorganisms B-10641, or Bacillus amyloliquefaciens, the Russian National Collection of Industrial Microorganisms B-10642, or Bacillus amyloliquefaciens, the Russian National Collection of Industrial Microorganisms B-10643, or a mixture thereof in ratio 1:1:1 with titre of each bacterial strain not less than 1·104 CFU/g or 1·104 CFU/ml.

EFFECT: preparation possess bactericidal and fungicidal activity.

7 cl, 9 dwg, 12 tbl, 10 ex

FIELD: agriculture.

SUBSTANCE: method of plant cultivation comprises includes treatment of plant seeds prior to their sowing and of plant in the growing season with a biological product in liquid form. As a biological product, a mixture of strains of bacteria of B. subtilis of RNCIM B-10641, B. amyloliquefaciens RNCIM B-10642 and B. amyloliquefaciens RNCIM B-10643 is used, with a titer of not less than 106 CFU/ml in the form of an aqueous suspension.

EFFECT: invention provides increase in productivity of plants and restoration of soil microbiocenosis.

3 cl, 4 dwg, 5 tbl, 9 ex

FIELD: biotechnologies.

SUBSTANCE: invention relates to oligonucleotide primers and the method of their use for detection of Lactobacillus delbrueckii subspecies bulgaricus in starter cultures. Proposed synthetic oligonucleotide primers have nucleotide sequences: Lbul4F 5'-GGCCAGCCAGATCGCCAGC-3' and Lbul5R 5'-GACCAGGTCGCTGTCCGGC-3'. The proposed method includes performance of PCR. In case a DNA ferment is detected with size of 409 base pairs. a conclusion is made on availability of Lactobacillus delbrueckii subspecies bulgaricus in the investigated biomaterial.

EFFECT: inventions may be used in milk processing industry for detection and identification of strains and cultures Lactobacillus delbrueckii subspecies bulgaricus in starter cultures used in production of cultured milk foods.

2 cl, 1 tbl, 3 ex

FIELD: biotechnologies.

SUBSTANCE: nutrient medium contains HMF - agar, erythrocytic mass from donor's human blood, serum of cattle and yeast extract at the specified ratio.

EFFECT: invention makes it possible to increase sensitivity of medium to extracted microorganisms, to improve growth properties of nutrient medium and to simplify method of its preparation.

FIELD: biotechnologies.

SUBSTANCE: new strain of bacteria Pasteurella trehalosi is proposed, where the specified bacteria are positive in respect to beta-haemolysis, positive in respect to oxidase, positive in respect to catalase, negative in respect to urease, positive in respect to nitrates, negative in respect to indole, MacConkey-positive, positive in respect to glucose, positive in respect to saccharose, positive in respect to mannitol, negative in respect to arabinose, negative in respect to cellobiose, positive in respect to xylose, negative in respect to salicin, negative in respect to ornithine, negative in respect to esculin, negative in respect to alpha-fucosidase, positive in respect to beta-galactosidase. Also the strain of bacteria Mannheimia haemolytica is proposed. These bacteria are deposited under registration numbers ATCC No. PTA-3667, ATCC No. PTA-3668, ATCC No. PTA-3669.

EFFECT: immunisation of chickens with the purpose to prevent disease caused by above bacteria.

7 cl, 22 dwg, 2 tbl, 6 ex

FIELD: biotechnologies.

SUBSTANCE: nutrient medium contains monosubstituted potassium phosphate, magnesium sulphate, sodium phosphate, iron citrate, glycocol, monosubstituted sodium glutamate, glycerine, agar, potato broth, whey of cattle and distilled water at specified ratios.

EFFECT: invention makes it possible to increase yield of biomass of L-forms of mycobacteria and to reduce time of biomass accumulation.

1 tbl

FIELD: food industry.

SUBSTANCE: invention relates to food industry, in particular to production of food additives based on sea weeds. The method for production of a functional food additive (being a source of food fibres, bioactive polysaccharides, iodine-containing substances, a combination of ω-3 ω-6 polyunsaturated fatty acids) envisages sea weeds treatment. The milled sea weeds are maintained in water at a ratio of 1:10 at a temperature of 20-25°C during 20-40 minutes for swelling. Then one introduces probiotic microorganisms i.e. Lactobacillus genius lactic acid bacteria into the produced jelly-like sea weed substrate at t=20-25°C during 12-24 hours till concentration is equal to no less than 107 CFU/g to accrete biomass. The invention allows to produce a functional food additive based on sea weeds and having a complex preventive and probiotic action. The produced additive is used in the recipe of mince meat products in an amount of 5% of the raw material weight.

EFFECT: invention promotes semi-products quality enhancement, structure and appearance improvement and storage life extension.

1 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to biotechnology and concerns oligonucleotide primers for B.mallei genetic typing. The presented primers are complementary to a differentiation fragment BMA0416 of an equinia agent genome, possess activity of upstream and downstream primers in an amplification reaction and have the following structure: 5'-TGGCGGAGTATGGATGCTG-3' - BmVAT6-Ch2s 5'-GAACGAGAACACCTACGACCTGAT-3' - BmVAT6-Ch2as.

EFFECT: presented invention may be used in practical healthcare for detection of the differentiation DNA fragment BMA0416 of the equinia agent.

3 dwg, 3 ex

FIELD: chemistry.

SUBSTANCE: invention relates to biotechnology. Obtained is a Lactobacillus rhamnosus 38k bacteria strain, having antagonistic activity with respect to pathogens and opportunistic pathogens, including Candida yeast fungi, average adhesion and self-aggregation properties, high surface hydrophobicity, average coaggregation, is deposited in the Russian National Collection of Industrial Microorganisms (VKPM) under registration number VKPM V11155.

EFFECT: strain can be used in production of probiotic bacterial preparations, biologically active food additives, fermented milk and non-fermented food products.

5 tbl

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to biotechnology, veterinary science and plant protection. The bacterial strain Bacillus subtilis IC-1435-1-1 is deposited in the Russian National Collection of Industrial Microorganisms, registration number B-10641. The bacterial strain Bacillus amyloliquefaciens IC-1436-1-23 is deposited in the Russian National Collection of Industrial Microorganisms, registration number B-10642. The bacterial strain Bacillus amyloliquefaciens IC-1437-1-23 is deposited in the Russian National Collection of Industrial Microorganisms, registration number B-10643. The strains are produced by selection and promote the recovery of microbiocenoses in the soil and animals gastrointestinal tract, possess bactericidal, fungicidal and virucidal activity. A preparation on the basis of the strains contains an excipient or water with a bacterial biomass in the spore form Bacillus subtilis, the Russian National Collection of Industrial Microorganisms B-10641, or Bacillus amyloliquefaciens, the Russian National Collection of Industrial Microorganisms B-10642, or Bacillus amyloliquefaciens, the Russian National Collection of Industrial Microorganisms B-10643, or a mixture thereof in ratio 1:1:1 with titre of each bacterial strain not less than 1·104 CFU/g or 1·104 CFU/ml.

EFFECT: preparation possess bactericidal and fungicidal activity.

7 cl, 9 dwg, 12 tbl, 10 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine and pharmacology, and represents a method for probiotic correction of postintoxification psychosis in the patients suffering alcohol dependence syndrome, consisting in restoring the hepatic function ensured by increasing the detoxification and metabolic functions with the use of biologically active additives containing the probiotic culture of bifidus bacteria 10 CFU/g 3 times a day and lactobacilli 108 CFU/g 3 times a day for 5 days.

EFFECT: provided reduced activity of the AST enzymes, activated pigment, protein and synthetic hepatic function, restored normal flora of the colon.

2 ex

FIELD: chemistry.

SUBSTANCE: invention relates to microbiology and biotechnology and can be used in food industry and medicine. The microbial strain of Lactobacillus plantarum Tensia DSM 21380 produces conjugated linoleic acid (CLA), hydrogen peroxide (H2O2), nitrogen monoxide (NO), contains plantaricin encoding genes and has antioxidant activity. This strain and its liophilised form are used to prepare an antimicrobial and hypotensive probiotic, a dairy product and a medicinal agent which lowers blood pressure. The strain and its liophilised form are also used to increase polyamine turnover in the body, to attain a dominant position among intestinal lactic bacteria in the gastrointestinal tract and to prolong the shelf life of a dairy product.

EFFECT: use of the invention enables to lower blood pressure, suppress undesirable microflora and inhibit oxidative processes.

12 cl, 8 dwg, 31 tbl, 7 ex

FIELD: biotechnologies.

SUBSTANCE: strain Enterococcus hirae BC - 37 having high antagonistic activity is deposited in the Russian National Collection of Industrial Microorganisms (RNCIM) under the registration number VKPMV-10090 and may be used, for instance, in production of such cultured milk foods as kefir, cottage cheese or ryazhenka.

EFFECT: invention makes it possible to produce a strain having high antagonistic activity and high speed of milk turning sour.

3 ex

FIELD: biotechnologies.

SUBSTANCE: strain Lactobacillus gallinarum I-12, having high antagonistic activity is deposited in the Russian National Collection of Industrial Microorganisms (RNCIM) under the registration number VKPM V - 10134 and may be used in production, for instance, of such cultured milk foods, as kefir, acidophilic milk, acidophilic-yeast milk.

EFFECT: invention makes it possible to produce a strain having high antagonistic activity and high speed of milk turning sour.

3 ex

FIELD: biotechnology.

SUBSTANCE: strain of Enterococcus hirae "И"-27 with high antagonistic activity is deposited in the Russian National Collection of Industrial Microorganisms (RNCIM) under registration number of RNCIM B-10091 and can be used in production, for example, of fermented milk products such as kefir, cottage cheese or fermented baked milk.

EFFECT: invention enables to obtain a strain with high antagonistic activity and a high rate of milk fermentation.

3 ex

FIELD: biotechnology.

SUBSTANCE: strain of Enterococcus hirae "И"-29 with high antagonistic activity, deposited in the Russian National Collection of Industrial Microorganisms (RNCIM) under registration number of RNCIM B-10088, and can be used in production, for example, of fermented milk products such as kefir, cottage cheese or fermented baked milk.

EFFECT: invention enables to obtain a strain with high antagonistic activity and a high rate of milk fermentation.

3 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to medicine and pharmaceutical industry and represents a composition with anti-infectious activity presented in the solid dosage form for oral administration in the form of a powder, representing a balanced complex containing a probiotic agent, an adsorbent and an excipient; the probiotic agent is sterilised cultural fluid containing metabolites of the strain Bacillus subtilis VKPM (Russian National Collection of Industrial Microorganisms) No. B-2335; the adsorbent is zeolite; the excipient is calcium stearate or aerosil; the composition is characterised by the fact that it additionally contains a high-active immunomodulatory agent representing a complex of polysaccharides - products of polymer enzymatic hydrolysis of internal and external layers of brewers' yeast cell coating in the form of β-glucane and mannan with the ingredients of the composition taken in specific proportions, wt %.

EFFECT: invention provides high effectiveness and versatility with respect to dangerous bacterial and viral infections; it is storage safe and stable.

11 ex, 10 tbl, 10 dwg

FIELD: biotechnologies.

SUBSTANCE: probiotic lacto-amylovorin is produced by means of depth growth of the strain Lactobacillus amylovorus RNCIM B-6253 on the liquid nutrient medium, which contains the following: corn extract - 10 ± 0.01 ml, lactose - 20 ± 0.005 g, chemically deposited chalk - 0.5 ± 0.01 g, triple-substituted citric-acid sodium - 7.5 ± 0.05 g, 3-water acetous sodium - 2 ± 0.01 g, iron sulfate - 0.1± 0.001 g, 5-water manganese sulfate - 0.16 ± 0.002 g, hydrolysate of dry nonfat milk - up to l. Subsequent extraction of the target product in liquid condition or in the form of a dry powder is carried out with preliminary addition of a stabiliser to a cultural liquid or to a protective medium used when producing the probiotic in the form of the dry powder. The stabiliser is selected from: sodium metabisulfite, sodium hydrosulfite and ascorbic acid.

EFFECT: invention provides for stable production of a probiotic with high values of a titre of antimicrobial bodies not only in a cultural liquid, but also after its treatment required for production of different pharmaceutical forms of a preparation.

3 cl, 2 tbl, 3 ex

FIELD: biotechnology, microbiology, medicine.

SUBSTANCE: invention relates to the strain Lactobacillus paracasei CNCM I-2116 used for diarrhea prophylaxis causing by pathogenic microorganisms. Supernatant of this strain culture elicits ability to prevent colonization of intestine with pathogenic microorganisms causing diarrhea also and this strain is designated for preparing agent used for prophylaxis and/or treatment of disorders associated with diarrhea. Agent for oral administration represents therapeutically effective dose of the strain L. paracasei CNCM I-2116 or supernatant of its culture and acceptable foodstuff. Invention provides the enhanced viability of the strain in its applying and effectiveness in prophylaxis of adhesion to intestine cells and invasion to intestine cells of pathogenic microorganisms causing diarrhea.

EFFECT: valuable medicinal properties of strain.

5 cl, 8 dwg, 10 ex

Up!